A group of experts at the Institute of Hematology, Union Hospital, and Hoa Trung University of Science and Technology (Vu Han - China) has successfully developed a new cancer treatment method using viral vectors to create immune cells in the body.
Instead of having to grow T cells outside, this method helps re- lap trinh T cells by using a gene therapy virus targeting cancer cells.
The new method overcomes the disadvantages of traditional CAR-T therapy, which requires many weeks of complex processing and costs up to more than 1 million yuan. By ignoring intermediate steps such as cell collection, culture and tienated chemotherapy, the therapy only takes 72 hours to start to be effective.
In the first phase of the clinical trial, four patients with multiple myeloma were truyenlized with viral vector vectors from November 19 to January 20. As of April 1, two people had reached a state of complete peripheration, the remaining two people responded positively when the tumor clearly shrinched after 28 days.
The study was published in early July in the medical journal Lancet and was assessed by Chinese experts as a breakthrough. If large-scale testing is successful, the cost of cancer treatment can be reduced by more than 80% and the current model of CAR-T can be changed.
